<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30088537</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>17</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>17</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">1980-5322</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>73</Volume>                    <PubDate>                        <Year>2018</Year>                        <Month>08</Month>                        <Day>02</Day>                    </PubDate>                </JournalIssue>                <Title>Clinics (Sao Paulo, Brazil)</Title>                <ISOAbbreviation>Clinics (Sao Paulo)</ISOAbbreviation>            </Journal>            <ArticleTitle>Intraoperative imprint cytology versus histological diagnosis for the detection of sentinel lymph nodes in breast cancer treated with neoadjuvant chemotherapy.</ArticleTitle>            <Pagination>                <MedlinePgn>e363</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S1807-59322018000100247</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.6061/clinics/2018/e363</ELocationID>            <Abstract>                <AbstractText Label="OBJECTIVES">To compare imprint cytology and paraffin section histology for sentinel lymph node detection in women with breast cancer treated with neoadjuvant chemotherapy.</AbstractText>                <AbstractText Label="METHOD">A cross-sectional study and report of the sentinel lymph node statuses of 64 patients with breast cancer who underwent intraoperative imprint cytology and neoadjuvant chemotherapy in a referral cancer institute in Rio de Janeiro, Brazil, between 2014 and 2016.</AbstractText>                <AbstractText Label="RESULTS">The mean age was 51 years. The most common histological type was invasive ductal carcinoma (93.75%), and the most common differentiation grade was 2 (62.5%). Overall, 153 lymph nodes were identified, with a mean of 2.39/case. Thirty-four lymph nodes tested positive for malignancy by imprint cytology, and 55 tested positive by histology. Of the 55 positive lymph nodes, 41 (74.5%) involved macrometastases, and 14 (25.5%) involved micrometastases. There were 21 false negatives with imprint cytology, namely, 7 for macrometastases and 14 for micrometastases, resulting in a rate of 17.6%. The sensitivity of imprint cytology was 61.8%, with a specificity and positive predictive value of 100%, a negative predictive value of 82.4% and an accuracy of 86.3%. The method presented null sensitivity for the identification of micrometastases.</AbstractText>                <AbstractText Label="CONCLUSIONS">The false-negative rate with imprint cytology was associated with the number of sentinel lymph nodes obtained. The rate found for complete response to neoadjuvant chemotherapy was comparable to the rates reported in the literature. The accuracy of imprint cytology was good, and its specificity was excellent for sentinel lymph node detection; however, the method was unable to detect lymph node micrometastases.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Delgado-Bocanegra</LastName>                    <ForeName>Ronald Enrique</ForeName>                    <Initials>RE</Initials>                    <AffiliationInfo>                        <Affiliation>Instituto Nacional do Cancer (INCA), Rio de Janeiro, RJ, BR.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Millen</LastName>                    <ForeName>Eduardo Camargo</ForeName>                    <Initials>EC</Initials>                    <AffiliationInfo>                        <Affiliation>Instituto Nacional do Cancer (INCA), Rio de Janeiro, RJ, BR.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Nascimento</LastName>                    <ForeName>Cristina Moreira do</ForeName>                    <Initials>CMD</Initials>                    <AffiliationInfo>                        <Affiliation>Instituto Nacional do Cancer (INCA), Rio de Janeiro, RJ, BR.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bruno</LastName>                    <ForeName>Karine de Aguiar</ForeName>                    <Initials>KA</Initials>                    <AffiliationInfo>                        <Affiliation>Instituto Nacional do Cancer (INCA), Rio de Janeiro, RJ, BR.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D003160">Comparative Study</PublicationType>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>02</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Brazil</Country>            <MedlineTA>Clinics (Sao Paulo)</MedlineTA>            <NlmUniqueID>101244734</NlmUniqueID>            <ISSNLinking>1807-5932</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2013 Oct 9;310(14):1455-61</RefSource>                <PMID Version="1">24101169</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Cir Bras. 2012 Dec;27(12):912-6</RefSource>                <PMID Version="1">23207760</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Langenbecks Arch Surg. 2010 Aug;395(6):685-91</RefSource>                <PMID Version="1">20012316</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1987 Feb 15;59(4):682-7</RefSource>                <PMID Version="1">3802027</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2013 Aug;20(8):2582-9</RefSource>                <PMID Version="1">23504119</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2010 Jul;122(2):453-7</RefSource>                <PMID Version="1">20532977</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ir J Med Sci. 2016 Feb;185(1):145-9</RefSource>                <PMID Version="1">25595827</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2017 Feb;31:40-45</RefSource>                <PMID Version="1">27810698</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst Monogr. 2001;(30):96-102</RefSource>                <PMID Version="1">11773300</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2005 Feb;16(2):259-62</RefSource>                <PMID Version="1">15668280</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Breast Cancer. 2016 Aug;16(4):299-304</RefSource>                <PMID Version="1">26993216</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2006 May 3;98(9):599-609</RefSource>                <PMID Version="1">16670385</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg. 2015 Mar;261(3):547-52</RefSource>                <PMID Version="1">25664534</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Surg. 2005 Sep;92(9):1068-80</RefSource>                <PMID Version="1">16106479</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2005 Oct 20;23(30):7703-20</RefSource>                <PMID Version="1">16157938</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Surg Oncol. 2009 Jan;35(1):16-20</RefSource>                <PMID Version="1">18554859</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Surg Oncol. 2016 Mar;42(3):326-32</RefSource>                <PMID Version="1">26774943</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Oncol. 2010 Jun;27(2):233-6</RefSource>                <PMID Version="1">19296239</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2010 Oct;11(10):927-33</RefSource>                <PMID Version="1">20863759</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Compr Canc Netw. 2017 Apr;15(4):433-451</RefSource>                <PMID Version="1">28404755</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2012 Oct;19(10):3144-51</RefSource>                <PMID Version="1">22847123</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am Surg. 2001 Jan;67(1):86-91</RefSource>                <PMID Version="1">11206905</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2014 May 1;32(13):1365-83</RefSource>                <PMID Version="1">24663048</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Tumour Biol. 2014 Jun;35(6):5741-6</RefSource>                <PMID Version="1">24590267</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2013 Jun;14(7):609-18</RefSource>                <PMID Version="1">23683750</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2007 Oct;8(10):881-8</RefSource>                <PMID Version="1">17851130</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018270" MajorTopicYN="N">Carcinoma, Ductal, Breast</DescriptorName>                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005188" MajorTopicYN="N">False Negative Reactions</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D007432" MajorTopicYN="N">Intraoperative Period</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D020360" MajorTopicYN="N">Neoadjuvant Therapy</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D060787" MajorTopicYN="N">Neoplasm Grading</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D061206" MajorTopicYN="N">Neoplasm Micrometastasis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016612" MajorTopicYN="N">Paraffin Embedding</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000071036" MajorTopicYN="N">Sentinel Lymph Node</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D021701" MajorTopicYN="N">Sentinel Lymph Node Biopsy</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2017</Year>                <Month>11</Month>                <Day>21</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>02</Month>                <Day>08</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>9</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>9</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30088537</ArticleId>            <ArticleId IdType="pii">S1807-59322018000100247</ArticleId>            <ArticleId IdType="doi">10.6061/clinics/2018/e363</ArticleId>            <ArticleId IdType="pmc">PMC6038057</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>